Choosing the right stent for patients with ST-segment elevation myocardial infarction: the evidence-based approach.
Primary percutaneous coronary intervention (PCI) with the implantation of new-generation drug-eluting stents (DES) is the preferred method of reperfusion in ST-segment elevation myocardial infarction (STEMI). More importantly, new-generation DES are recommended as the default option in all clinical conditions and lesion subsets. On the other hand, the interest in fully bioresorbable scaffolds (BRS) implantation, also in the setting of STEMI is growing. Also, dedicated stents technologies, i.e. mesh-covered stents and self-expanding stents may play role in the treatment of STEMI and thrombus containing lesions. This review discusses the evidence for different stent options in STEMI with a proposed selection strategy in contemporary primary PCI.